1-8 of 8
Masashi Miyauchi
Close
Sort by
Journal Articles

Efficient production of human neutrophils from iPSCs that prevent murine lethal infection with immune cell recruitment

Masashi Miyauchi, Yusuke Ito, Fumio Nakahara, Toshiya Hino, Fumi Nakamura, Yuki Iwasaki, Taiki Kawagoshi, Junji Koya, Akihide Yoshimi, Shunya Arai, Yuki Kagoya, Mineo Kurokawa
Journal: Blood
Blood (2021) 138 (24): 2555–2569.
https://doi.org/10.1182/blood.2021011576
Published: 2021
Includes: Supplemental data
Journal Articles

Synthetic Lethality-Based Approach Identified EED and BRD4 As Critical Survival Factorsin Acte Myeloid Leukemia with Monosomy 7

Kensuke Matsuda, MD, Yuki Kagoya, MD PhD, Sho Yamazaki, MD PhD, Masashi Miyauchi, MD PhD, Mineo Kurokawa, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1233.
https://doi.org/10.1182/blood-2019-123595
Published: 2019
Journal Articles

Primary Prophylaxis with Pegfilgrastim in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma: A Nation-Wide, Propensity Score Based Analysis

Kensuke Matsuda, MD, Taisuke Jo, Masashi Miyauchi, MD PhD, Kazuhiro Toyama, MD PhD, Kumi Nakazaki, Hideo Yasunaga, MD PhD, Mineo Kurokawa, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1605.
https://doi.org/10.1182/blood-2019-123611
Published: 2019
Journal Articles

Genetically Engineered Hematopoietic Progenitors Derived from Human Induced Pluripotent Stem Cells Achieve the Feeder-Free and Robust Production of Neutrophils with the Functional Capacity In Vivo

Masashi Miyauchi, Yusuke ITO, MD, Fumio Nakahara, MD PhD, Fumi Nakamura, MD PhD, Yuki Iwasaki, Taiki Kawagoshi, Yuki Kagoya, MD PhD, Shunya Arai, MD PhD, Mineo Kurokawa, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 720.
https://doi.org/10.1182/blood-2019-126348
Published: 2019
Journal Articles

Calcium/Calmodulin Dependent Protein Kinase 2 Gamma Is Identified As a Potential Therapeutic Target of Myelofibrosis Using Disease-Specific Induced Pluripotent Stem Cells

Masashi Miyauchi, MD PhD, Ken Sasaki, MD, Kazuki Taoka, MD PhD, Yosuke Masamoto, MD PhD, Sho Yamazaki, MD PhD, Shunya Arai, MD PhD, Mineo Kurokawa, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3054.
https://doi.org/10.1182/blood-2018-99-113285
Published: 2018
Journal Articles

Patient-Derived Induced Pluripotent Stem Cells Identified SLITRK4 As a Causative Gene of Chronic Myelomonocytic Leukemia

Sho Yamazaki, MD, PhD, Kazuki Taoka, MD, PhD, Shunya Arai, MD, PhD, Masashi Miyauchi, MD, PhD, Keisuke Kataoka, MD PhD, Akihide Yoshimi, MD, PhD, Mineo Kurokawa, MD, PhD
Journal: Blood
Blood (2016) 128 (22): 1134.
https://doi.org/10.1182/blood.V128.22.1134.1134
Published: 2016
Journal Articles

Patient-Derived Induced Pluripotent Stem Cells Revealed ADAM8/CD156 As a Novel Marker of TKI-Resistant Chronic Myeloid Leukemia Cells

Masashi Miyauchi, MD, PhD, Shunya Arai, MD, PhD, Akira Honda, MD PhD, Sho Yamazaki, MD, PhD, Keisuke Kataoka, MD PhD, Akihide Yoshimi, MD, PhD, Kazuki Taoka, MD, PhD, Keiki Kumano, MD, PhD, Mineo Kurokawa, MD, PhD
Journal: Blood
Blood (2016) 128 (22): 1878.
https://doi.org/10.1182/blood.V128.22.1878.1878
Published: 2016
Journal Articles

Modeling Chronic Myelomonocytic Leukemia Through Patient-Derived Induced Pluripotent Stem Cells

Keisuke Kataoka, MD, PhD, Kazuki Taoka, MD, PhD, Masashi Miyauchi, M.D., Ph.D., Masataka Hosoi, M.D., Ph.D., Keiki Kumano, MD, PhD, Shunya Arai, MD, PhD, Kazuhiro Toyama, M.D., Ph.D., Genta Nagae, M.D., Ph.D., Wei Qu, Ph.D., Shinichi Morishita, Ph.D., Hiroyuki Aburatani, M.D., Ph.D., Mineo Kurokawa, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 864.
https://doi.org/10.1182/blood.V122.21.864.864
Published: 2013